Apparently, the laws of gravity do not apply to North American startup investment.
For the fourth quarter in a row, the sum of venture capital poured into U.S. and Canadian companies rose sequentially and year-over-year. Altogether, investors are projected to put a whopping $35.3 billion to work. That money is dispersed across seed-stage through technology-growth stage deals in the third quarter of 2018, the highest projected total since Crunchbase began tracking this data.
A lot of really big, late-stage deals pushed the totals to new highs. Rounds of $100 million or more—once a rarity in startup-land—were a near-daily occurrence. Investments of a few hundred million popped up frequently as well for companies in transportation, real estate, and even e-cigarettes.
Early-stage dealmaking also held up at robust levels, though with a tinge less frenzied exuberance. Exits were pretty good, too, bolstered by several prominent tech unicorns launching well-received IPOs. Acquisition activity was more muted, but a few big deals still unfolded during the quarter.
Below, we break down the numbers in greater detail, focusing on Q3 investment totals and round counts, stage-by-stage performance, largest rounds, and biggest exits.
Investment Totals
These are extravagant times in the venture capital world. Total investment rose nearly 13 percent quarter-over-quarter across all stages in Q3, according to Crunchbase projections. That’s a big jump and pretty astounding considering that Q2 was itself an extraordinarily spendy quarter for all things startup-related.
Year-over-year, the gains are even greater. The $35.3 billion invested in Q3 of 2018 represents a rise of nearly 19 percent from the same quarter last year. In the chart below, we look at how the investment totals break down over the past five quarters:
Round Counts
While venture deals are getting bigger, they’re not getting more numerous. The number of projected seed, venture and tech growth rounds in Q3 of 2018 is up year-over-year, but is actually down a bit from Q2 levels.
Crunchbase projects a total of 3,825 rounds across all stages for Q3 of 2018. That’s up 16 percent from year-ago levels, but down about 7 percent from the prior quarter. In the chart below, we look at how round counts break down over the past five quarters:
The lead investors in these rounds are par for the course, with the Amazon Alexa Fund being a notable addition.
Angel And Seed Stage
Seed-stage funding also held up at historically high levels, though it appears to have slowed a bit from the prior quarter.
Crunchbase projects that nearly 2,200 U.S. and Canadian companies secured angel or seed rounds in Q3 of 2018. That’s down a couple percent from the prior quarter and up about 15 percent from year-ago levels.
Total investment in seed-stage companies, meanwhile, is projected at around $1.4 billion, also down a bit from the prior quarter and up from year-ago levels.
Y Combinator was the most active seed-stage investor with 53 investments. Techstars, the runner-up, came in with a comparatively modest 25 investments.
Early Stage
Early-stage (Series A and B) investment remained at historically high levels in the just-ended quarter. However, there wasn’t a sharp spike in funding.
Overall, investors put $12.3 billion to work in early stage rounds in Q3 of 2018. That’s roughly flat with the prior quarter and up about 25 percent from year-ago levels.
A handful of extra-large deals lifted the totals. While supergiant rounds are normally relegated to late stage, we saw a number at Series A and B as well, primarily for companies in biotech, but also enterprise software and autonomous driving.
Early stage rounds usually go to young companies, but that isn’t always the case. Several of the biggest Q3 Series A and B fundings were actually for fairly mature companies that waited to dip into the venture pool, including Samumed, founded in 2008, and Automation Anywhere, founded back in 2003.
Below, we look at some of the biggest early stage funding recipients:
Y Combinator once again tops the list of early stage investors, but with only a slim margin over Andreessen Horowitz.
Late Stage And Growth Stage
Over the past few quarters, the most dramatic trend in startup funding has to be the rise of supergiant rounds.
Until recently, these monolithic fundings of $100 million or more were a rarity in venture circles. Now, they’re commonplace. For Q3 of 2018, for instance, at least 47 U.S. and Canadian companies raised supergiant rounds, including at least ten valued at $300 million or more.
These giant financings contributed to pushing late stage funding totals to what appear to be record levels. For Q3 of 2018, investors put just over $20 billion into late stage deals (Series C and later). That’s up a staggering 61 percent from year-ago levels, and up 36 percent from the prior quarter.
Established unicorns drank up much of the funding. The list includes enterprise messaging platform Slack, stationary bike and spin class purveyor Peloton, and secondhand shopping app Letgo.
Real estate startups also saw a big jump, thanks to SoftBank. In the final week of the quarter, the firm’s Vision Fund backed $400 million rounds for two U.S.-based unicorns, Compass, a tech-enabled real estate brokerage, and Opendoor, a company that offers fast home sales.
Below we look at 10 of the largest late-stage funding recipients:
New Enterprise Associates was the most willing to make late-stage deals in Q3, with the Softbank Vision fund notably falling to the bottom of the list.
Exits
So it’s clear from the numbers that investors put a lot of money into the startup ecosystem last quarter. But how did they do in terms of getting money back?
Overall, it looks like a very solid run for IPOs in Q3, while returns from M&A were a bit more lackluster. We’ll look at returns for both exit types below.
First, IPOs. The window for tech and life science offerings was wide open this past quarter, and quite a few venture-backed companies capitalized on the opportunity to go public. Standouts on the tech front included Eventbrite and SurveyMonkey, two long standing unicorns that launched well-received IPOs. This biggest monster hit, however, was Canadian cannabis company Tilray, recently valued around $13 billion (and no, it’s not profitable).
Public market investors have been extra willing lately to overlook unprofitability for companies with growing revenues, and that’s contributing to the current venture-backed IPO boomlet. Over the first three quarters of this year, 83 percent of U.S.-listed IPOs lost money in the 12 months leading up to their debuts, and Q3 in no way deviated from trend.
Below, we look at some of the largest North American venture-backed companies that IPO’d this past quarter:
Now let’s look at M&A. For Q3, the biggest deal was Cisco’s purchase of cybersecurity unicorn Duo Security for $2.35 billion. There were a number of other sizeable deals announced during the quarter as well, several of which we highlight below:
There’s no surprise in seeing M&A levels underwhelm compared to the prior quarter. It was always going to be tough for Q3 of this year to measure up to Q2, which included Microsoft’s GitHub acquisition, the largest purchase of a venture-backed tech company in years. That said, Q3 still turned out to be a reasonably strong quarter for acquisitions; it just wasn’t spectacular.
Looking Ahead
As we’ve noted previously, current investment conditions do show many characteristics of a market peak: a large pool of available venture and growth capital, a wide-open IPO market, unusually big funding rounds, and little pressure for profitability.
However, our datasets aren’t engineered to predict how long the current bullishness will last. All we know is that, eventually, market cycles do turn.
Illustration: Li-Anne Dias
Stay up to date with recent funding rounds, acquisitions, and more with the Crunchbase Daily.
